CatalystEarnings

$CORT. CORCEPT THERAPEUTICS

CORT

$81.93

+1.83%

What changed

FQ3 FY2026 (ends Sep) | reported Nov 03: - Revenue: $340M - Adj EPS: $1.01 vs $0.84 🟢 ⚠️ one-time - GAAP op margin: 33.7% (📈 +28.8pp YoY) Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $1.10B-$1.20B

Why it matters

FQ3 FY2026 (ends Sep) | reported Nov 03:

Sources

sec